transferrin-crm107
Recombinant proteinexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2002 (NCT00052624)
Timeline
2000s
- Jan 1, 2002
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- SerotransferrinBINDING AGENT
TF binding agent
Chemistry & pharmacology
- Multi-specific
- No
- Payload
- diphtheria toxin
Oral
No
Parenteral
No
Topical
No
Also known as
- transferrin-crm107
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00052624 | Phase 1 | Jul 1, 2002 | Xenova Biomedix |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Xenova Biomedix | For profit | 1 | 1 | 1 | 2002 |
1 organizations
Page 1 / 1